CARE Canadian ALS Riluzole Evaluation

Clinical trial NCT00542412 · COMPLETED

Trial details

NCT number: NCT00542412
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2001-01-01
Enrollment: 414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.